CurrentBlue Cross Blue Shield - OklahomaPolicy CPCPLAB050

Urine Culture Testing for Bacteria

Reimbursement criteria for urine culture testing (including isolate identification and antibiotic susceptibilities) for Blue Cross Blue Shield - Oklahoma members; describes when testing is reimbursable and when it is not, and notes that plan documents and provider contracts govern in case of conflict.

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy CPCPLAB050

Change TypeNo material change

Effective DateNov 1, 2022

Next Review Date

Key ActionProviders must submit accurate documentation and use valid HIPAA-approved code sets when submitting claims; claims are subject to review and plan or contract terms.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

7explicit reimbursement rules

Nov 1, 2022effective date

1.0version

createdhistory

Urine Culture Reimbursement Criteria

Urine culture reimbursement criteria

Reimbursement stance for urine culture testing (with isolate identification and antibiotic susceptibilities if applicable):

Pregnancy: Reimbursable: urine culture testing for any urinary tract infection, asymptomatic or symptomatic, including suspected cystitis, pyelonephritis, and asymptomatic bacteriuria.

Pre‑urological intervention: Reimbursable: asymptomatic patients prior to undergoing urological interventions that breach the mucosa.

Symptomatic patients: Reimbursable: patients exhibiting at least one sign or symptom of possible UTI or bacteriuria (see note on signs/symptoms).

Pyelonephritis: Reimbursable: urine culture testing to assess pyelonephritis.

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy CPCPLAB050

Change TypeNo material change

Effective DateNov 1, 2022

Next Review Date

Key ActionProviders must submit accurate documentation and use valid HIPAA-approved code sets when submitting claims; claims are subject to review and plan or contract terms.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Documentation and Coding Expectations

Documentation Required

Documentation, coding, and claim‑review requirements

Providers must submit accurate documentation of the services performed and bill using valid HIPAA‑approved code sets. Claims are subject to code edit protocols and claim review, which may include review against benefit coverage, provider contracts, medical policies, CPCPs, and coding software logic; upon request, providers should submit additional documentation.

Use valid code combinations from HIPAA‑approved code sets (CPT®, HCPCS, ICD‑10-CM/PCS, NDC, DRG, etc.) and follow industry coding guidelines (UB Editor, AMA CPT® guidance, CMS NCCI/CCI edits).
Claims are subject to code edit protocols and claim review; plan documents or provider contracts govern in case of conflict.
Be prepared to provide additional documentation upon request to support the claim.

OpenPayer

Urine Culture Testing for Bacteria

Urine Culture Reimbursement Criteria

Coding Guidance

Documentation and Coding Expectations

Signs and Symptoms